Having previously receivd awards as Immunetech Pharmaceuticals, the firm is now known as Tanabe Research Laboratories U.S.A., Inc. (TRL), and is a wholly owned subsidiary of Tanabe Seiyaku Co., Ltd., that is headquartered in Osaka, Japan. Withthe subsiduary firm remaining in originall location the focus of TRL is defined as being that to discover, optimize and develop innovative pharmaceutical products to address unmet medical needs in major therapeutic categories. Tanabe Research Laboratories had been initially focused on small molecule drug discovery in the field of metabolics and inflammation/immunology. At the beginning of 2010, the organization was restructured to direct efforts towards biologics instead of small molecule compounds
